Dec 5, 2017
In this episode, Hall T. Martin conducts an interview with Randy Goldsmith, founder and director of Rapamycin Holdings. Rapamycin Holdings is a San Antonio-based company that is developing and commercializing a patented oral formulation of Rapamycin for the prevention of cancer progression and recurrence. Hall and Randy discuss his background in the industry. They also discuss the FDA process and challenges as well as measuring progress.